Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: Results from the cooperative health research in the region of augsburg survey S4 (KORA S4)

Diabetes

Volumn 54, Issue SUPPL. 2, 2005, Pages

  Herder, Christian ^a   Haastert, Burkhard ^a   Müller Scholze, Sylvia ^a   Koenig, Wolfgang ^b   Thorand, Barbara ^c   Holle, Rolf ^c   Wichmann, H Erich ^c   Scherbaum, Werner A ^a   Martin, Stephan ^a   Kolb, Hubert ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RANTES; URIC ACID;

ADULT; AGED; BODY MASS; CIRCULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; REVIEW; RISK FACTOR; SEX; UPREGULATION;

AGED; BLOOD PRESSURE; CHEMOKINES, CC; CHEMOKINES, CXC; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; GLUCOSE INTOLERANCE; HEALTH SURVEYS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MALE; MIDDLE AGED; RANTES; REFERENCE VALUES;

EID: 33644594409     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.suppl_2.S11     Document Type: Review

References (31)

1. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
2. Festa A, D'Agostino R, Tracey RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
3. Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H: Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45:805-812, 2002
4. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W: C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 163:93-99, 2003
5. Pickup JC: Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813-823, 2004
6. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 15:675-705, 1997
7. Gerard C, Rollins BJ: Chemokines and disease. Nat Immunol 2:108-115, 2001
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
9. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartiglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003
10. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A: From blood monocytes to adipose-tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53:1285-1292, 2004
11. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B: Serum interleukin-8 level is increased in diabetic patients (Letter). Diabetologia 42:117-118, 1999
12. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activates platelets inpatients with diabetes. Clin Exp Immunol 121:437-443, 2000
13. Esposito K, Nappo F, Giugliano F, di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D: Cytokine milieu tends toward inflammation in type 2 diabetes (Letter). Diabetes Care 26:1647, 2003
14. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G: High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening: the KORA survey 2000. Diabetologia 46:182-189, 2003
15. Kaplan AP: Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol 124:423-431, 2001
16. Romagnani S: Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38:881-885, 2002
17. Illig T, Bongardt F, Schöpfer A, Holle R, Müller S, Rathmann W, Koenig W, Meisinger C, Wichmann HE, Kolb H, KORA Study Group: The endotoxin receptor TLR4 is not associated with diabetes or components of the metabolic syndrome. Diabetes 52:2861-2864, 2003
18. Illig T, Bongardt F, Schopfer A, Müller-Scholze S, Rathmann W, Koenig W, Thorand B, Vollmert C, Holle R, Kolb H, Herder C, Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg: Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G. J Clin Endocrinol Metab 89:5053-5058, 2004
19. Hense HW, Filipiak B, Doring A, Stieber J, Liese A, Keil U: Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany: results from the 1984/85, 1989/90 and 1994/95 survey. CVD Prevention 1:318-327, 1998
20. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM: The DENIS Study Group: Deutsche Nikotinamid Interventions-Studie. Diabetologia 39:1351-1356, 1996
21. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 47:7-14, 1988
22. International Committee for Standardization in Haematology: Recommendation for a selected method for the measurement of plasma viscosity. J Clin Pathol 37:1147-1152, 1994
23. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F: Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 94:253-261, 2004
24. Simonini A, Moscucci M, Muller DWM, Bates ER, Pagani FD, Burdick MD, Strieter RM: IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101:1519-1526, 2000
25. Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC: Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res 92:371-377, 2003
26. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144, 2002
27. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto J de P, Morrow DA, de Lemos JA: Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44:1812-1818, 2004
28. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I: Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J Clin Endocrinol Metab 87:4602-4606, 2002
29. Bruun JM, Pedersen SB, Richelsen B: Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86:1267-1273, 2001
30. He G, Bruun JM, Lihn AS, Pedersen SB, Richelsen B: Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro. Biochem Biophys Res Commun 310:878-883, 2003
31. Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Szelachowska M, Linalska I: Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol 2:5, 2003